Takeda Pharmaceutical Co. Ltd. (TYO:4502) has recently made waves in the pharmaceutical industry with its move to acquire Irish-based drug manufacturer Shire PLC. President and CEO Christophe Weber recently took...
pharmaceutical
Interview: Takeda Pharmaceutical CEO Talks Shire Deal, Shifting Business Structure – Part 1
Takeda Pharmaceutical Co. Ltd. (TYO:4502) is bringing Irish-based drug manufacturer Shire PLC under its umbrella. Entailing an acquisition price of around 46 billion pounds ($62.4 billion), this is the largest...
Taiyo Holdings Looks to Produce Drugs In-House
Taiyo Holdings Co. Ltd. (TYO:4626) has acquired long-listed drug business operations from Chugai Pharmaceutical Co. Ltd. (TYO:4519), and plans to acquire its own factory within the fiscal year to produce...
Interview: Novartis Pharma President Kazunari Tsunaba Talks Market Adjustments, New Treatments and Technologies
Novartis Pharma KK appears to have turned the corner in terms of business performance. Sitting down for an interview with The Chemical Daily, president Kazunari Tsunaba said that sales for...
Memory T Cells Found to Alter Immunological Response Based on Intensity of Antigenic Stimulation
An international research group formed by the Institute of Physical and Chemical Research (Riken), Osaka University and Yale University has discovered that the strength at which memory T cells are...
NOF Develops Monodisperse PEG for Antibody Drug Delivery
NOF Corp. (TYO:4403) has developed a monodisperse polyethylene glycol (PEG) as a drug delivery system (DDS) material usable in antibody drugs. Sales of the PEG began in March. Unlike typical...
Western Chemical Companies in Japan – Part 12: Occidental Chemical
The Chemical Daily recently conducted a round of interviews with the heads of Japanese subsidiaries of Western chemical companies. For this installment, we talked with Toru Ogawa, president of Occidental...
Nihon Medi-Physics Embarks on Development of New Cancer Treatment
Nihon Medi-Physics Co. Ltd., a radiopharmaceutical manufacturing venture equally funded by Sumitomo Chemical Co. Ltd. (TYO:4005) and GE Healthcare, will begin working toward the establishment of theranostics – a completely...
Mitsubishi Chemical Looks to Accelerate M&A Efforts in Performance Products
Mitsubishi Chemical Corp. is moving to accelerate its M&A strategies in the area of performance products. With an investment and loan framework of 1.7 trillion yen ($15.08 billion) established as...
Engineering Companies Push Continuous Production Processes for Pharmaceuticals
Japanese engineering companies are directing more effort toward marketing continuous production processes for pharmaceutical products. Continuous production involves the creation of a very safe plant with a compact floor for...
Mitsui Chemicals to Promote New Heat Seal Coating for Pharmaceutical Blister Packs in India, China
Mitsui Chemicals Inc. (TYO:4183) announced on Nov. 21 that it has developed Chemipearl XSP, a heat seal coating series for pharmaceutical blister packaging. The water-based product is free of organic...
Chugai Pharmaceutical to Start Production in China
Chugai Pharmaceutical Co. Ltd. (TYO:4519) has announced that it will start manufacturing drugs in China, renting out a factory in the city of Taizhou to commence production of unstable angina...
Nearly 20 Drug Companies Now Share Quality Control Info in PEGASS
Japanese drug makers have begun sharing quality control information on pharmaceutical excipients. About two years ago, seven companies established the Pharmaceutical Excipients GMP Audit Sharing System (PEGASS) for jointly contracting...
Mitsui Takes Equity in Russia’s R-Pharm to Become Strategic Partner
Mitsui & Co. Ltd. (TYO:8031) has entered into a strategic partnership with JSC R-Pharm, the largest pharmaceutical company in Russia. Mitsui will acquire 10 percent of R-Pharm’s shares for roughly...
Japanese Pharmaceutical Industry Faces Fierce Competition to Secure Key Talent
The intensity of competition for talent looks set to increase in Japan’s pharmaceutical industry. According to Hays Specialist Recruitment Japan KK, commonly known as Hays Japan, salaries – excluding bonuses...
YMC to Complete Its Lineup of Antibody Drug Separation, Purification Products
YMC Co. Ltd. is strengthening its efforts as a supplier of separation and purification columns as well as packing media used in the manufacture of antibody pharmaceuticals. Beginning this spring,...
Industry Outlook 2017: Pharmaceuticals Part 4 – Digital Health
The digital health field is garnering much attention within the pharmaceutical industry as a growth strategy. In concert with the evolution of the Internet of Things (IoT) and mobile technologies,...
Industry Outlook 2017: Pharmaceuticals Part 2 – M&As
Long-listed drugs often stem from low molecular drugs that have been an important source of revenue for pharmaceutical manufacturers. Being sought now, however, are innovative products that exhibit unprecedented effectiveness...
Industry Outlook 2017: Pharmaceuticals Part 1 – Authorized Generics
The Japanese pharmaceutical industry is facing a difficult business situation, as the government is pushing for more widespread use of lower priced generic drugs in an attempt to hold down...
Pharmaceutical Industry Feels Deep Impact With 2016 Drug Pricing Reform
An aspect with huge impact from the 2016 drug pricing system reform has been the provision for exceptional reprising. Implemented in April, the newly adopted system provides for price reductions...
